CellSeed Inc. (7776.T)
JPY 408.0
(-7.69%)
JPY 408.0
(-7.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 151.25 Million JPY | -4.72% |
| 2022 | 158.75 Million JPY | -0.78% |
| 2021 | 160 Million JPY | 0.0% |
| 2020 | 160 Million JPY | 0.0% |
| 2019 | - JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 147.5 Million JPY | -1.26% |
| 2024 Q1 | 149.37 Million JPY | -1.24% |
| 2023 Q2 | 154.37 Million JPY | -1.2% |
| 2023 Q4 | 151.25 Million JPY | -1.22% |
| 2023 Q1 | 156.25 Million JPY | -1.57% |
| 2023 FY | 151.25 Million JPY | -4.72% |
| 2023 Q3 | 153.12 Million JPY | -0.81% |
| 2022 Q3 | 160 Million JPY | 0.0% |
| 2022 FY | 158.75 Million JPY | -0.78% |
| 2022 Q4 | 158.75 Million JPY | -0.78% |
| 2021 FY | 160 Million JPY | 0.0% |
| 2020 FY | 160 Million JPY | 0.0% |
| 2019 FY | - JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 93.876% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 95.912% |
| Linical Co., Ltd. | 3 Billion JPY | 94.962% |
| Trans Genic Inc. | 2.25 Billion JPY | 93.299% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -6456.134% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 93.881% |
| AnGes, Inc. | 362.67 Million JPY | 58.296% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -41.555% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 99.796% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | 35.906% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 86.361% |
| Carna Biosciences, Inc. | 182.97 Million JPY | 17.337% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | 82.912% |
| RaQualia Pharma Inc. | 367.71 Million JPY | 58.868% |
| Chiome Bioscience Inc. | 291 Million JPY | 48.024% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 94.126% |
| PeptiDream Inc. | 22.79 Billion JPY | 99.337% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | 52.01% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | 77.256% |
| Healios K.K. | 4.53 Billion JPY | 96.663% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -34.444% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -5.878% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -55.061% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | 83.794% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | 84.375% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | 79.107% |
| StemCell Institute Inc. | 8.78 Million JPY | -1621.881% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |